drugset / Trial / NCT02070380
Crossover Comparison of MultiHance and Dotarem
RandomizedCrossoverTriple-blindDiagnostic
Summary
This study aims at a comparison between MultiHance at a dose of 0.1 mmol/kg and 0.05 mmol/kg and Dotarem at a dose of 0.1 mmol/kg in brain tumor patients to show superiority of MultiHance.
Timeline
- Start
- 2014-02
- Primary completion
- 2015-03
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gadobenate dimeglumine | Diagnostic / imaging agent | 0.05 mmol | — |
| Subject | Gadobenate dimeglumine | Diagnostic / imaging agent | 0.1 mmol | — |
| Subject | Gadoterate meglumine | Diagnostic / imaging agent | 0.1 mmol | — |